New breast cancer medication accepted by SMC February 16, 2021 Scottish Medicines Consortium (SMC) has accepted PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer. Leupro... Read More... FeaturedNews 0
